Investigation of the effect of cerebrolysin on patients with head trauma and diffuse axonal injury

Traumatic brain injury is one of the main causes of death and disability in America and Iran and every year about of 53,000 people die in America because of this. Moderate to severe brain damage causes of death and disability in physical and cognitive activities. Cerebrolysin improves performance and accelerates regeneration of damaged nerve cells. The aim of this study was to investigate the effect of cerebrolysin in patients with head trauma and diffuse axonal injury. In a clinical trail study that perfored in Neurosurgery department of Tabriz University of Medical Scienences on patients head trauma that had diffuse axonal injury, the effect of the effect of cerebrolysin in patients with head trauma and diffuse axonal injury evaluated. Twenty five patients underwent tratment by cerebrolysin and 28 patients evaluated in control group. Mean age of patients in control group was 30.53±16.54 year and in case group was 27.84±15.24 year(P=0.542). Mean Admission day count in control group patients was 15.82±13.19 day and in control group was 23.72±21.91 day(P=0.114). Mean Admission GCS score of patients in control group was 6.78±0.91 in case group was 6.72± 0.84(P=0.788). Mean Discharge time GCS score of patients in control group was 9.57±4.96 in case group was 13.32±3.31(P=0.002). Mean Discharge time GOS score of patients in control group was 2.96±1.59 in case group was 4.08±1.11(P=0.005). Significant increase was found in GCS score of patients in both group but mean increase rate of GCS in control group was 2.78± 4.98 and in case group was 6.60±3.26 that significantly higher in case group than control group. Eight patient of control group and 2 patients of case group, died due to the severity of the trauma. Although the mortality rate in the control group was approximately four times more than the case group but the difference was not statistically significant. KEYWORDS

[1]  G. Keilhoff,et al.  Effects of cerebrolysin on rat Schwann cells in vitro. , 2014, Acta histochemica.

[2]  E. Youness,et al.  Cerebrolysin attenuates cerebral and hepatic injury due to lipopolysaccharide in rats. , 2013, Drug discoveries & therapeutics.

[3]  M. Shakeri,et al.  Effect of progesterone administration on prognosis of patients with diffuse axonal injury due to severe head trauma , 2013, Clinical Neurology and Neurosurgery.

[4]  S. Zamudio,et al.  Combined administration of cerebrolysin and donepezil induces plastic changes in prefrontal cortex in aged mice , 2012, Synapse.

[5]  A. Federico,et al.  Cerebrolysin administration reduces oxidative stress-induced apoptosis in limphocytes from healthy individuals , 2012, Journal of cellular and molecular medicine.

[6]  N. Bornstein,et al.  Accelerated recovery from acute brain injuries: clinical efficacy of neurotrophic treatment in stroke and traumatic brain injuries. , 2012, Drugs of today.

[7]  M. Wald,et al.  Surveillance for traumatic brain injury-related deaths--United States, 1997-2007. , 2011, Morbidity and mortality weekly report. Surveillance summaries.

[8]  M. Serpe,et al.  Cerebrolysin adjuvant treatment in Broca's aphasics following first acute ischemic stroke of the left middle cerebral artery , 2010, Journal of medicine and life.

[9]  A. Ciurea,et al.  Neuroprotective and consequent neurorehabilitative clinical outcomes, in patients treated with the pleiotropic drug cerebrolysin , 2009, Journal of medicine and life.

[10]  G. Ladurner,et al.  Neuroprotective treatment with Cerebrolysin in patients with acute stroke: a randomised controlled trial , 2005, Journal of Neural Transmission.

[11]  V. Couceiro,et al.  Positive effects of Cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study , 2003, International clinical psychopharmacology.

[12]  X. L. Zhu,et al.  Does intensive rehabilitation improve the functional outcome of patients with traumatic brain injury? Interim result of a randomized controlled trial , 2001, British journal of neurosurgery.

[13]  N. A. Shchudlo,et al.  [The effect of cerebrolysin on the regeneration of the peripheral nerve depending on the scheme of paraneural administration]. , 2013, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[14]  S. A. Zhivolupov,et al.  [The сomparative analysis of neyromidin and cerebrolysin effects on neurodynamic processes during craniocerebral injury]. , 2011, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[15]  S. Gauthier,et al.  Cerebrolysin: a review of its use in dementia. , 2009, Drugs & aging.

[16]  X. L. Zhu,et al.  Beneficial effect of cerebrolysin on moderate and severe head injury patients: result of a cohort study. , 2005, Acta neurochirurgica. Supplement.

[17]  Y. Heqin,et al.  Efficacy of FPF 1070 (Cerebrolysin) in Patients with Alzheimer’s Disease , 2000 .

[18]  L. Turner-Stokes,et al.  Effectiveness of brain injury rehabilitation. , 1999, Clinical rehabilitation.